Véronique Mansat-De Mas

20PUBLICATIONS
204CO-AUTHORS
Haematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Jun 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.

Aristi Damaskou, Rachael Wilson, Malgorzata Gozdecka

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

|Nov 06, 2023
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Vincent Fregona, Manon Bayet, Mathieu Bouttier

|Jul 09, 2023
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.

Charly Courdy, Loïc Platteeuw, Charlotte Ducau

Pageof 4

Frequent Collaborators

11 joint publications

Christian Récher

8 joint publications

Jean-Emmanuel Sarry

7 joint publications

Sarah Bertoli

7 joint publications

François Vergez